UNDERWRITING AGREEMENTUnderwriting Agreement • June 20th, 2016 • Ontario
Contract Type FiledJune 20th, 2016 JurisdictionThe undersigned, Mackie Research Capital Corporation (“Mackie”) and Echelon Wealth Partners Inc. (“Echelon”, and together with Mackie, the “Underwriters”), understand that Immunovaccine Inc. (the “Company”) proposes to issue and sell (the “Offering”) 14,550,000 units of the Company (the “Units”), each Unit consisting of one common share of the Company (a “Unit Share”) and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”), with each Warrant entitling the holder thereof to acquire one common share (a “Warrant Share”) in the capital of the Company at a price of $0.72 per Warrant Share until a date that is 24 months from the Closing Date (as defined below). The Underwriters, hereby severally, and not jointly, nor jointly and severally, offer to purchase from the Company all of the Units on a “bought deal” basis, at the purchase price of $0.55 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of